Arbutus Biopharma (ABUS) Other Operating Expenses (2013 - 2026)
Arbutus Biopharma (ABUS) posted Other Operating Expenses of $213,000 for Q2 2026, down 18.1% from $260,000 a year earlier but up 1.9% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Other Operating Expenses (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Other Operating Expenses at Arbutus Biopharma was -$1.97 million; for FY2025, it came in at -$1.83 million.
- In prior years, Arbutus Biopharma's Other Operating Expenses was $2.63 million in FY2024, $69,000 in FY2023 (-96.9%), $2.23 million in FY2022 (+19.3%) and $1.87 million in FY2021 (+295.8%).
- Quarterly Other Operating Expenses has run from a low of -$2.66 million in Q4 2025 to a high of $1.89 million in Q4 2024 over five years.
- On a year-over-year basis, Other Operating Expenses increased in four of the last seven quarters, with growth averaging 117.1%.
- The strongest year-over-year quarter for Other Operating Expenses in the past five years was Q4 2022, with growth of 733.7%; the weakest was Q4 2023, with a decline of 85.9%.
- According to Business Quant data, Other Operating Expenses for the three prior quarters was $209,000 (Q1 2026), -$2.66 million (Q4 2025) and $268,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Arbutus Biopharma | 826.41 Mn | 453.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 213,000.00 |
| Mar 31, 2026 | 209,000.00 |
| Dec 31, 2025 | -2.66 Mn |
| Sep 30, 2025 | 268,000.00 |
| Jun 30, 2025 | 260,000.00 |
| Mar 31, 2025 | 299,000.00 |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 344,000.00 |
| Jun 30, 2024 | 211,000.00 |
| Mar 31, 2024 | 180,000.00 |
| Dec 31, 2023 | 227,000.00 |
| Sep 30, 2023 | 205,000.00 |
| Jun 30, 2023 | -636,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 215,000.00 |
| Jun 30, 2022 | 208,000.00 |
| Mar 31, 2022 | 201,000.00 |
| Dec 31, 2021 | 193,000.00 |
| Sep 30, 2021 | 409,000.00 |
API Access
Arbutus Biopharma Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();